In a very latest analyze, we claimed the identification and also the characterization of a brand new atypical opioid receptor with one of a kind adverse regulatory Houses to opioid peptides.1 Our outcomes confirmed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a broad-spectrum sca